Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Meisel

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
The New England Journal of Medicine|June 9, 2021
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-ThalassemiaRoland Meisel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2023
Secondary Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation for Sickle Cell Disease Inform Gene Therapy ApproachesRoland Meisel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2007
Pneumococcal vaccination of children after hematopoietic stem cell transplantation: timing is crucialRoland Meisel, Dagmar Dilloo
Blood|February 2, 2013
Peripheral blood stem cells versus bone marrow in pediatric unrelated donor stem cell transplantationRoland Meisel, Thomas Klingebiel, Dagmar Dilloo, et al.
Journal of Occupational and Environmental Medicine|May 24, 2003
Early workplace intervention for employees with musculoskeletal-related absenteeism: a prospective controlled intervention studyBengt B Arnetz, Berit Sjögren, Berit Rydéhn, et al.
Blood Advances|January 4, 2018
Osteonecrosis in children and adolescents with acute lymphoblastic leukemia: a therapeutic challengeMichaela Kuhlen, Marina Kunstreich, Kathinka Krull, et al.
Stem Cells International|September 13, 2012
Basic biology and clinical application of multipotent mesenchymal stromal cells: from bench to bedsideSelim Kuçi, Reinhard Henschler, Ingo Müller, et al.
Blood|March 6, 2004
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradationRoland Meisel, Andree Zibert, Maurice Laryea, et al.
Deutsches Arzteblatt International|March 23, 2023
Donor Selection for Allogeneic Hematopoietic Cell TransplantationKatharina Fleischhauer, Thuong Hien Tran, Roland Meisel, et al.
Clinical Immunology (Orlando, Fla.)|November 7, 2012
Treosulfan-based conditioning in DOCK8 deficiency: complete lympho-hematopoietic reconstitution with minimal toxicitySujal Ghosh, Friedhelm R Schuster, Ilka Fuchs, et al.
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|June 9, 2021
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-ThalassemiaRoland Meisel
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2023
Secondary Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation for Sickle Cell Disease Inform Gene Therapy ApproachesRoland Meisel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2007
Pneumococcal vaccination of children after hematopoietic stem cell transplantation: timing is crucialRoland Meisel, Dagmar Dilloo
Blood|February 2, 2013
Peripheral blood stem cells versus bone marrow in pediatric unrelated donor stem cell transplantationRoland Meisel, Thomas Klingebiel, Dagmar Dilloo, et al.
Journal of Occupational and Environmental Medicine|May 24, 2003
Early workplace intervention for employees with musculoskeletal-related absenteeism: a prospective controlled intervention studyBengt B Arnetz, Berit Sjögren, Berit Rydéhn, et al.
Blood Advances|January 4, 2018
Osteonecrosis in children and adolescents with acute lymphoblastic leukemia: a therapeutic challengeMichaela Kuhlen, Marina Kunstreich, Kathinka Krull, et al.
Stem Cells International|September 13, 2012
Basic biology and clinical application of multipotent mesenchymal stromal cells: from bench to bedsideSelim Kuçi, Reinhard Henschler, Ingo Müller, et al.
Blood|March 6, 2004
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradationRoland Meisel, Andree Zibert, Maurice Laryea, et al.
Deutsches Arzteblatt International|March 23, 2023
Donor Selection for Allogeneic Hematopoietic Cell TransplantationKatharina Fleischhauer, Thuong Hien Tran, Roland Meisel, et al.
Clinical Immunology (Orlando, Fla.)|November 7, 2012
Treosulfan-based conditioning in DOCK8 deficiency: complete lympho-hematopoietic reconstitution with minimal toxicitySujal Ghosh, Friedhelm R Schuster, Ilka Fuchs, et al.
Pageof 13